Role of EEG in Differentiation Between Ischemic and Hemorrhagic Stroke
Launched by ASSIUT UNIVERSITY · May 14, 2025
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how electrical activity in the brain, measured by a test called EEG, can help doctors tell the difference between two types of strokes: ischemic (caused by a blockage in a blood vessel) and hemorrhagic (caused by bleeding in the brain). The researchers want to see if the EEG results can also give clues about how well patients might recover after a stroke.
To participate in this study, you need to be between 18 and 80 years old and have had a stroke within the last 72 hours. This includes those who have had their first ischemic stroke or a hemorrhagic stroke confirmed by imaging tests. If you decide to join, you will undergo an EEG, which is a safe and painless procedure that records your brain's electrical activity. The trial is currently looking for participants, and it’s important to know that certain medical conditions or previous treatments may make you ineligible. Your involvement could help improve stroke care in the future!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age above 18 and below 80 years.
- • Acute Ischemic stroke: ischemic arteria cerebri media infarct confirmed by MRI.
- • Acute Hemorrhagic stroke: spontaneous intraparenchymal bleeding confirmed by CT.
- • Stroke onset \<72 hours before expected time of performing EEG.
- • First-ever ischemic stroke.
- • Measurable deficit on the National Institute of Health Stroke Scale (NIHSS).
- • Able to give and sign informed consent.
- Exclusion Criteria:
- • Transient Ischemic Attacks (TIAs).
- • Greater than 72 hours past the initial insult.
- • Patients with subarachnoid haemorrhage, traumatic haemorrhage (epidural/subdural bleeding), cerebral venous sinus thrombosis, indication for urgent neurosurgical intervention.
- • History of other central nervous system diseases.
- • Any signs unfit for MRI/EEG scan.
- • Injury or active infection of electrode cap placement area.
- • Claustrophobia; recognition disorder.
- • Known skull defect or head trauma.
- • Previous neurological procedure (metallic implant, brain pace, cranial operation history).
- • Significant physical impairment that would restrict the ability to use the portable EEG devices.
- • Presence of malignancy or systemic rheumatic disease
- • Non-stroke disease or lesion affecting the sensorimotor system.
- • Alcohol or drug addiction.
- • Presence of pump/shunt.
- • Presence of Malignancy.
- • Presence of severe cognitive impairment.
- • History of epilepsy or taking medication due to epilepsy.
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Asyut, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported